Lung cancer is the leading cause of cancer deaths worldwide, mainly because it gets detected late. The discovery by the ...

Approximately 40.5 percent of Americans will be diagnosed with cancer at some point in their life. It’s a diagnosis no ...

The European Commission approves AstraZeneca's Imfinzi for treating patients with limited-stage small-cell lung cancer based ...

A recent analysis shows that additional invasive staging modalities lead to relevant changes in target volume in some ...

AstraZeneca's eneboparatide met its Phase 3 trial goal for chronic hypoparathyroidism, while the EU approved Imfinzi for ...

Economic Toxicity, Lung Cancer, Multi-Center Trial, Correlation Analysis Share and Cite: Mao, R.M. and Peng, L.Y. (2025) Multi-Center Investigation on the Level of Economic Toxicity in Patients with ...

Chen, F. (2025) Advances in the Application of Deep Learning in Prognostic Models for Non-Small Cell Lung Cancer. Health, 17, ...

The safety profile for Imfinzi was generally manageable and consistent with the known profile of this medicine.

AbbVie has pointed to a very strong launch trajectory for Elahere, with sales rocketing to $480 million last year, almost ...

Taiwanese researchers have linked higher survival rates and decreased tumor spread in patients with adenocarcinoma of the ...

Chinese drug maker Akeso, whose new cancer drug has outperformed a leading Western peer in clinical studies, is being hailed ...

Could the food on your plate be influencing your lung health? A new study has revealed a striking link between diet and lung ...